- $77.96m
- $8.61m
- $25.38m
- 10
- 30
- 43
- 16
Annual cashflow statement for Invivyd, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -65.3 | -227 | -241 | -199 | -170 |
| Depreciation | |||||
| Non-Cash Items | 40.1 | 19.3 | 37 | 17.6 | 19.8 |
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 10.7 | 22.8 | -16.1 | 5.89 | -23.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -14.6 | -185 | -220 | -173 | -170 |
| Capital Expenditures | — | -0.084 | -1.71 | -0.615 | -0.14 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -50.6 | -229 | 281 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | -50.7 | -231 | 281 | -0.14 |
| Financing Cash Flow Items | — | -3.38 | 0 | -0.149 | -0.597 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 130 | 663 | 0.506 | 1.04 | 39.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 115 | 427 | -450 | 109 | -131 |